Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) is associated with alterations in the gut microbiota. Changes in microbial composition alone do not adequately explain how these communities influence mucosal homeostasis, immune regulation, and tumor-associated inflammation. The persistence of beneficial commensals within dysbiotic ecosystems challenges the assumption that microbial presence reflects functional activity. Although microbial metabolites and bacterial extracellular vesicles (BEVs) are increasingly recognized as mediators of host–microbiota communication, their relative contributions and interactions remain insufficiently resolved in CRC. Here, we propose the SCIM axis—Short-chain fatty acid production, Control of mucin dynamics, Immunomodulation, and Mucosal integrity—as a framework for investigating the functional state of the intestinal mucosa. We hypothesize that mucosal homeostasis depends not only on microbial activities but also on their integration with host responses. Accordingly, disruption of metabolic and extracellular signaling networks may contribute to functional insufficiency even when commensal populations remain detectable. Within this framework, soluble bacterial products and BEVs represent communication routes whose effects may vary according to microbial origin, molecular cargo, epithelial barrier status, and inflammatory context. In particular, BEVs provide a route for delivering microbial proteins, lipids, nucleic acids, and cell-envelope components to epithelial and immune cells, thereby engaging innate immune sensing pathways and shaping mucosal inflammatory responses. To translate this hypothesis into a testable model, we outline readouts for each SCIM component: short-chain fatty acid profiling and microbial functional gene analysis; MUC2 expression, mucus organization, and mucinolytic activity; cytokine profiles and TLR/NOD–NF-κB-associated signaling; and epithelial barrier assessment through transepithelial electrical resistance, permeability assays, and tight junction markers. We further propose fractionation and reconstitution strategies to distinguish vesicle-associated activities from soluble factors and determine whether their effects are independent, additive, synergistic, or antagonistic. Commensals, including Akkermansia , Roseburia , and Faecalibacterium , together with CRC-associated pathobionts such as Fusobacterium nucleatum , provide biological contexts in which to investigate these relationships. By connecting microbial activity, extracellular communication, and host responses, the SCIM axis offers an approach to studying mucosal functional sufficiency and its disruption in CRC. Rather than introducing another taxonomic signature, this framework provides a basis for evaluating mechanisms of microbiota-associated mucosal dysfunction and, following validation, may inform biomarker and microbiome-directed therapeutic development.
No takes yet. Share an insight, caveat, or question.
Inostroza et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: